Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 279-283, January 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunz, B. A.
Right arrow Articles by Mis, J. R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunz, B. A.
Right arrow Articles by Mis, J. R. A.

Mutational Specificities of 1,3-Bis(2-chloroethyl)-1-nitrosourea and Nitrogen Mustard in the SUP4-o Gene of Saccharomyces cerevisiae1

Bernard A. Kunz2 and Joseph R. A. Mis

Department of Microbiology, The University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N2

A collection of 346 mutations arising in the SUP4-o gene of the yeast Saccharomyces cerevisiae following treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or nitrogen mustard was analyzed by DNA sequencing. Both agents induced all possible types of base-pair substitution as well as deletions and double mutations. The base-pair changes consisted primarily of events at G·C pairs and were distributed throughout the gene. However, the distributions differed for the two drugs, and a prominent substitution hotspot was detected for nitrogen mustard. BCNU induced a substantial fraction of deletions the majority of which were recovered at a hotspot encompassing a tract of five G·C pairs. In contrast, nitrogen mustard generated relatively few deletions, but substantially more double mutations were recovered than with treatment with BCNU. Neither agent exhibited a preference for contiguous G·C sites, and more than one quarter of the mutations occurred at G·C sites, flanked by A·T pairs or at A·T pairs indicating that mutagenesis was not restricted to G·C runs. The data indicate that for BCNU and nitrogen mustard, monoadducts may play a role in mutagenesis, and site-specific mutability is influenced by factors in addition to the G·C richness of the sequence involved.

1 This investigation was supported by Grant G1757 from NSERC Canada, by the University of Manitoba Research Committee of Senate, and by the Manitoba Careerstart '87 program.

2 To whom requests for reprints should be addressed.

Received 7/15/88. Revised 10/12/88. Accepted 10/19/88.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Inga, F.-X. Chen, P. Monti, A. Aprile, P. Campomenosi, P. Menichini, L. Ottaggio, S. Viaggi, A. Abbondandolo, B. Gold, et al.
N-(2-Chloroethyl)-N-nitrosourea Tethered to Lexitropsin Induces Minor Groove Lesions at the p53 cDNA That Are More Cytotoxic than Mutagenic
Cancer Res., February 1, 1999; 59(3): 689 - 695.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.